Labetalol infusion for refractory hypertension causing severe hypotension and bradycardia: an issue of patient safety, Patient Safety in Surgery
Por um escritor misterioso
Last updated 03 abril 2025

Incremental doses of intravenous labetalol are safe and effective and, at times, such therapy may need to be augmented by a continuous infusion of labetalol to control severe hypertension. Continuous infusions of labetalol may exceed the recommended maximum daily dose of 300 mg on occasion. We report a case in which hypertension occurring after an abdominal aortic aneurysm repair, initially responsive to intermittent intravenous beta-blockade, became resistant to this therapy leading to the choice of an intravenous labetalol infusion as the therapeutic option. The labetalol infusion resulted in a profound cardiovascular compromise in this postoperative critically ill patient. While infusions of labetalol have successfully been used, prolonged administration in the intensive care unit requires vigilance and the establishment of a therapeutic rationale/policy for interventions, such as the ready availability of glucagon, β-agonists, phosphodiesterase inhibitors, insulin, and vasopressin when severe cardiovascular depression occurs.

Hemodynamic Safety of Continuous Infusion Labetalol Versus Esmolol Combination Therapies for Type B Aortic Dissections

Links To And Excerpts From The IBCC Chapter, Hypertensive Emergency - Tom Wade MD

Hypertensive Crises: Urgencies and Emergencies

Treatment for Mild Chronic Hypertension during Pregnancy

LABETALOL HYDROCHLORIDE tablet, film coated

2023 American Heart Association Focused Update on the Management of Patients With Cardiac Arrest or Life-Threatening Toxicity Due to Poisoning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and

JCM, Free Full-Text

Part 12: Cardiac Arrest in Special Situations

Labetalol Tablets: Package Insert

Full article: Remifentanil versus labetalol for deliberate hypotensive anesthesia in children undergoing cochlear implantation: A randomized clinical trial
Recomendado para você
-
Labetalol Hydrochloride03 abril 2025
-
Labetalol Medicine book, Critical care nursing, Med surg nursing03 abril 2025
-
labetalol #oneampoule #eachmlcontain5mg #iv #antihypertensive #emergency #medicine03 abril 2025
-
LABESOL Labetalol Hydrochloride Tablets USP » SGPharma03 abril 2025
-
Labetalol Hydrochloride Injection, USP, 20 MG/ 4ML03 abril 2025
-
Labebet 100 MG Tablet (10): Uses, Side Effects, Price & Dosage03 abril 2025
-
Beta-Adrenergic Blocking Agent Labetalol HCl 5 mg / mL Intravenous Injection Multiple Dose Vial 40 mL03 abril 2025
-
Inj Labetalol Administration / Labetalol calculation03 abril 2025
-
LABETALOL HCL 200MG MDV 40ML - HIKMA PHARMACEUTICALS USA INC03 abril 2025
-
Pfizer Hospital US03 abril 2025
você pode gostar
-
Dead Mountain by Douglas Preston03 abril 2025
-
shao kahn Dövüş GO Mortal kombat art, Mortal kombat characters, Raiden mortal kombat03 abril 2025
-
My little pony png images03 abril 2025
-
Dicas de abertura para iniciantes em Xadrez03 abril 2025
-
Usual Suspects Poster03 abril 2025
-
Goblin Slayer Side Story: Year One Manga, Vol. 5 by Kumo Kagyu03 abril 2025
-
Bob's03 abril 2025
-
interminable rooms but all the entities has names - Comic Studio03 abril 2025
-
One Piece Creator Wants to End the Manga Within 3 Years03 abril 2025
-
10262023 by The Sopris Sun - Issuu03 abril 2025